Podcasts Innovative solutions to the drug pricing crisis: the pharmap... In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Dr Colin Banas, chief medical officer at DrFirst.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.